SARS-CoV-2 antibody status in patients with cancer, health care workers

What The Study Did:


This study evaluates whether there are differences in SARS-CoV-2 seroprevalence and antibody levels in patients with cancer compared with health care workers in Japan.

Authors:


Tatsuya Yoshida, M.D., Ph.D., of the National Cancer Center Hospital in Tokyo, is the

corresponding author.

To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/

(doi:10.1001/jamaoncol.2021.2159)

Editor’s Note:

The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###

Media advisory:

The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

https:/

/

jamanetwork.

com/

journals/

jamaoncology/

fullarticle/

10.

1001/

jamaoncol.

2021.

2159?guestAccessKey=

8aeadda1-2dff-4136-9127-a1ac36668722&utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_content=

tfl&utm_term=

053121